{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:38:47Z","timestamp":1760852327072},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.2174\/187153006778250000","type":"journal-article","created":{"date-parts":[[2008,4,18]],"date-time":"2008-04-18T00:44:03Z","timestamp":1208479443000},"page":"259-269","source":"Crossref","is-referenced-by-count":15,"title":["Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?"],"prefix":"10.2174","volume":"6","author":[{"given":"Udo","family":"Oppermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Endocrine\u201a Metabolic & Immune Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/77053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:55:35Z","timestamp":1448290535000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5303&volume=6&issue=3&spage=259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187153006778250000","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}